Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Kinesio Taping for Neurogenic Bowel Dysfunction in Spinal Cord Injury

10 luglio 2026 aggiornato da: Meltem Gunes Akinci, Pamukkale University

Effectiveness of Kinesio Taping on Neurogenic Bowel Dysfunction in Individuals With Spinal Cord Injury: A Randomized Controlled Trial

Neurogenic bowel dysfunction is a common complication of spinal cord injury and may cause constipation, difficulty with defecation, prolonged bowel care, incomplete evacuation, fecal incontinence, and reduced quality of life. This randomized controlled trial aims to evaluate the effectiveness of Kinesio Taping added to a routine bowel management program in adults with spinal cord injury and upper motor neuron-type neurogenic bowel dysfunction.

Thirty participants will be randomly assigned to one of two parallel groups. The control group will receive a routine bowel management program, while the intervention group will receive Kinesio Taping in addition to the routine bowel management program. Kinesio Taping will be applied to the lower abdominal and lumbosacral regions three times per week for 4 weeks.

The primary outcome will be defecation frequency recorded using a 7-day bowel diary. Secondary outcomes will include stool consistency, defecation duration, perceived constipation severity, neurogenic bowel dysfunction severity, and health-related quality of life. Assessments will be performed before and after the 4-week intervention.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

30

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Adults aged 18 years or older with traumatic or nontraumatic spinal cord injury
  • Neurological level of injury at T12 or above
  • Upper motor neuron-type neurogenic bowel dysfunction
  • Duration of spinal cord injury longer than 6 months
  • Ability and willingness to provide written informed consent

Exclusion Criteria:

  • Age younger than 18 years
  • Neurological level of injury below T12
  • Gastrointestinal disease diagnosed before the spinal cord injury, including irritable bowel syndrome or inflammatory bowel disease
  • History of conservative treatment for neurogenic bowel dysfunction within the previous 6 months
  • Colostomy or history of bowel surgery
  • Neurological disease other than spinal cord injury that may cause gastrointestinal or anal sphincter dysfunction
  • Cognitive impairment that may interfere with participation in the study

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Routine Bowel Management Program
Participants in this arm will receive an individualized routine bowel management program based on their clinical condition for 4 weeks. The program may include scheduled bowel care, dietary and fluid recommendations, appropriate positioning, physical activity, abdominal massage, rectal evacuation techniques, suppositories, enemas, and oral or rectal laxatives when clinically indicated. Participants will be instructed not to change their usual dietary habits during the study period.
Participants will receive an individualized routine bowel management program based on their clinical condition for 4 weeks. The program may include scheduled bowel care, dietary and fluid recommendations, appropriate positioning, physical activity, abdominal massage, rectal evacuation techniques, suppositories, enemas, and oral or rectal laxatives when clinically indicated. Participants will be instructed not to change their usual dietary habits during the study period.
Sperimentale: Kinesio Taping Plus Routine Bowel Management Program
Participants in this arm will receive Kinesio Taping in addition to the routine bowel management program for 4 weeks. Kinesio Taping will be applied to the lower abdominal and lumbosacral regions three times per week by the same experienced physician. The tape will remain in place for 2 days and will be removed before the next treatment session. A star-shaped correction technique will be applied to the lumbosacral region with 25%-50% tension, and an I-shaped correction technique will be applied to the lower abdominal region between the right and left anterior superior iliac spines. No tension will be applied to the ends of the tape
Participants will receive an individualized routine bowel management program based on their clinical condition for 4 weeks. The program may include scheduled bowel care, dietary and fluid recommendations, appropriate positioning, physical activity, abdominal massage, rectal evacuation techniques, suppositories, enemas, and oral or rectal laxatives when clinically indicated. Participants will be instructed not to change their usual dietary habits during the study period.
Kinesio Taping will be applied to the lower abdominal and lumbosacral regions three times per week for 4 weeks. The tape will remain in place for 2 days and will be removed before the next treatment session. A star-shaped correction technique will be applied to the lumbosacral region with 25%-50% tension. An I-shaped correction technique will be applied to the lower abdominal region between the right and left anterior superior iliac spines. No tension will be applied to the ends of the tape.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Defecation Frequency
Lasso di tempo: Baseline and at the end of the 4-week intervention
Defecation frequency will be recorded using a 7-day bowel diary and expressed as the total number of defecations during a 7-day period. Higher values indicate more frequent bowel movements.
Baseline and at the end of the 4-week intervention

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Bristol Stool Form Scale Score
Lasso di tempo: Baseline and at the end of the 4-week intervention
Stool consistency will be assessed using the 7-point Bristol Stool Form Scale. Type 1 indicates separate hard lumps, while Type 7 indicates entirely liquid stool. Types 3 to 5 generally represent softer or more desirable stool consistency.
Baseline and at the end of the 4-week intervention
Change in Perceived Constipation Severity
Lasso di tempo: Baseline and at the end of the 4-week intervention
Participants will rate the overall severity of constipation on a 10-cm Visual Analog Scale ranging from 0 to 10. A score of 0 indicates no constipation, while a score of 10 indicates very severe constipation.
Baseline and at the end of the 4-week intervention
Change in Neurogenic Bowel Dysfunction Score
Lasso di tempo: Baseline and at the end of the 4-week intervention
Neurogenic bowel dysfunction severity will be assessed using the 10-item Neurogenic Bowel Dysfunction Score. The total score ranges from 0 to 47, with higher scores indicating more severe neurogenic bowel dysfunction.
Baseline and at the end of the 4-week intervention
Change in Short Form-36 Health Survey Scores
Lasso di tempo: Baseline and at the end of the 4-week intervention
Health-related quality of life will be assessed using the 36-item Short Form Health Survey. The instrument includes eight subscales, each scored from 0 to 100. Higher scores indicate better perceived health status.
Baseline and at the end of the 4-week intervention
Change in Defecation Duration
Lasso di tempo: Baseline and at the end of the 4-week intervention
Defecation duration will be recorded in minutes using a 7-day bowel diary. Participants will record the time required to complete each bowel evacuation. A shorter duration indicates less time spent on bowel care.
Baseline and at the end of the 4-week intervention
Change in the Feeling of Complete Evacuation
Lasso di tempo: Baseline and at the end of the 4-week intervention
The feeling of complete bowel evacuation will be recorded in the 7-day bowel diary after each defecation. The outcome will be expressed as the number or proportion of defecations associated with a feeling of complete evacuation during the 7-day assessment period. Higher values indicate more frequent complete evacuation.
Baseline and at the end of the 4-week intervention
Change in Straining During Defecation
Lasso di tempo: Baseline and at the end of the 4-week intervention
Straining during defecation will be recorded in the 7-day bowel diary. The outcome will be expressed as the number or proportion of defecations accompanied by straining during the 7-day assessment period. Lower values indicate less frequent straining.
Baseline and at the end of the 4-week intervention
Change in Painful Defecation
Lasso di tempo: Baseline and at the end of the 4-week intervention
Painful defecation will be recorded in the 7-day bowel diary. The outcome will be expressed as the number or proportion of defecations associated with pain during the 7-day assessment period. Lower values indicate less frequent painful defecation.
Baseline and at the end of the 4-week intervention

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

30 luglio 2026

Completamento primario (Stimato)

30 ottobre 2026

Completamento dello studio (Stimato)

30 ottobre 2026

Date di iscrizione allo studio

Primo inviato

10 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

10 luglio 2026

Primo Inserito (Effettivo)

15 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

15 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi